
Co-Diagnostics (CODX) Market Capitalization Overview
Market Cap: $7.10M as of May 19, 2026
$7.10M
$161.50M (95.79%)past month
As of May 19, 2026, Co-Diagnostics (CODX) has a market capitalization of $7.10M. Over the past 30 days, its market cap has increased by 64.52%, while in the last 12 months, it has decreased by -97.77%.
Market capitalization represents the total value of Co-Diagnostics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Co-Diagnostics (CODX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Co-Diagnostics (CODX)helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Co-Diagnostics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Co-Diagnostics (CODX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Co-Diagnostics (CODX)helps investors assess the company's size and compare it with competitors for better investment decisions.
Co-Diagnostics (CODX) Market Cap & Key Trends
See Co-Diagnostics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Co-Diagnostics (CODX)
Order type
Buy in
Order amount
Est. shares
0 shares
Co-Diagnostics (CODX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| May 1, 2026 | $167.52M | +64.52% |
| Apr 1, 2026 | $101.82M | -29.57% |
| Mar 2, 2026 | $144.56M | -4.97% |
| Feb 2, 2026 | $152.12M | -56.47% |
| Jan 2, 2026 | $349.46M | -33.05% |
Co-Diagnostics (CODX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $7.10M | -97.77% |
| 2025 | $317.91M | -57.25% |
| 2024 | $743.71M | -39.20% |
| 2023 | $1.23B | -47.66% |
| 2022 | $2.34B | -74.20% |
| 2021 | $9.07B | — |
FAQs About Co-Diagnostics (CODX) Market Cap
As of May 19, 2026, the market capitalization of Co-Diagnostics (CODX) is $7.10M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Co-Diagnostics’s market capitalization has decreased by -95.79%, changing from $168.60M to $7.10M as of May 19, 2026.
In the last 3 months, Co-Diagnostics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Co-Diagnostics’s market capitalization decreased from $743.71M in January to $317.91M in December, reflecting a -57.25% change.
In the past five years, Co-Diagnostics (CODX) has had a compound annual growth rate (CAGR) of -48.83% in market capitalization. This means its market cap has shrunk at an average rate of -48.83% per year.